Johns Hopkins-Led Study Finds Convalescent Plasma Can Be Effective Early COVID-19 Therapy

Johns Hopkins Medicine and University of Maryland Medical System Partnering to Deliver More Than $4 Million Worth of Medical Supplies to Ukraine

Mutations Leading to Omicron Variant Did Not Enable Virus to Fully Escape Immune System

Johns Hopkins School of Medicine Dean and Johns Hopkins Medicine CEO Paul B. Rothman, M.D., to Retire

Get Boosted: New Study Underscores Need for COVID-19 Booster Shots for Older Adults

Johns Hopkins Medicine Surpasses 1.5 Million Telemedicine Visits Since Start of Pandemic

Promising Anti-Cancer Drug Also May Function as COVID-19 Antiviral Therapy

Johns Hopkins All Children’s First Female President Celebrates One Year at Hospital

Johns Hopkins Medicine-Led Consortium to Receive Up to $200 Million to Fight TB Globally

Nanoparticle Therapy May Help Patients Hospitalized With Severe COVID-19 Infections